Atomic solution structure of Mycobacterium abscessus F‐ATP synthase subunit ε and identification of Ep1MabF1 as a targeted inhibitor. (5th June 2022)
- Record Type:
- Journal Article
- Title:
- Atomic solution structure of Mycobacterium abscessus F‐ATP synthase subunit ε and identification of Ep1MabF1 as a targeted inhibitor. (5th June 2022)
- Main Title:
- Atomic solution structure of Mycobacterium abscessus F‐ATP synthase subunit ε and identification of Ep1MabF1 as a targeted inhibitor
- Authors:
- Shin, Joon
Harikishore, Amaravadhi
Wong, Chui Fann
Ragunathan, Priya
Dick, Thomas
Grüber, Gerhard - Abstract:
- Abstract : Mycobacterium abscessus ( Mab ) is a nontuberculous mycobacterium of increasing clinical relevance. The rapidly growing opportunistic pathogen is intrinsically multi‐drug‐resistant and causes difficult‐to‐cure lung disease. Adenosine triphosphate, generated by the essential F1 FO ATP synthase, is the major energy currency of the pathogen, bringing this enzyme complex into focus for the discovery of novel antimycobacterial compounds. Coupling of proton translocation through the membrane‐embedded FO sector and ATP formation in the F1 headpiece of the bipartite F1 FO ATP synthase occurs via the central stalk subunits γ and ε. Here, we used solution NMR spectroscopy to resolve the first atomic structure of the Mab subunit ε ( Mab ε), showing that it consists of an N‐terminal β‐barrel domain (NTD) and a helix–loop–helix motif in its C‐terminal domain (CTD). NMR relaxation measurements of Mab ε shed light on dynamic epitopes and amino acids relevant for coupling processes within the protein. We describe structural differences between other mycobacterial ε subunits and Mab ε's lack of ATP binding. Based on the structural insights, we conducted an in silico inhibitor screen. One hit, Ep1 Mab F1, was shown to inhibit the growth of Mab and bacterial ATP synthesis. NMR titration experiments and docking studies described the binding epitopes of Ep1 Mab F1 on Mab ε. Together, our data demonstrate the potential to develop inhibitors targeting the ε subunit of Mab F1 FO ATPAbstract : Mycobacterium abscessus ( Mab ) is a nontuberculous mycobacterium of increasing clinical relevance. The rapidly growing opportunistic pathogen is intrinsically multi‐drug‐resistant and causes difficult‐to‐cure lung disease. Adenosine triphosphate, generated by the essential F1 FO ATP synthase, is the major energy currency of the pathogen, bringing this enzyme complex into focus for the discovery of novel antimycobacterial compounds. Coupling of proton translocation through the membrane‐embedded FO sector and ATP formation in the F1 headpiece of the bipartite F1 FO ATP synthase occurs via the central stalk subunits γ and ε. Here, we used solution NMR spectroscopy to resolve the first atomic structure of the Mab subunit ε ( Mab ε), showing that it consists of an N‐terminal β‐barrel domain (NTD) and a helix–loop–helix motif in its C‐terminal domain (CTD). NMR relaxation measurements of Mab ε shed light on dynamic epitopes and amino acids relevant for coupling processes within the protein. We describe structural differences between other mycobacterial ε subunits and Mab ε's lack of ATP binding. Based on the structural insights, we conducted an in silico inhibitor screen. One hit, Ep1 Mab F1, was shown to inhibit the growth of Mab and bacterial ATP synthesis. NMR titration experiments and docking studies described the binding epitopes of Ep1 Mab F1 on Mab ε. Together, our data demonstrate the potential to develop inhibitors targeting the ε subunit of Mab F1 FO ATP synthase to interrupt the coupling process. Abstract : Mycobacterium abscessus ( Mab ) is of increasing clinical relevance. Its F1 FO ‐ATP synthase, composed of the subunits α3 :β3 :γ:ε: a : b‐δ : b':c 9, provides the essential energy currency, ATP. Herein, we resolved the atomic NMR structure of Mab's F‐ATP synthase subunit ε ( Mab ε) and identified this subunit as a new anti‐ Mab compound target. These paved the way to design the novel Ep1 Mab F1 compound targeting Mab ε, and inhibiting the growth of Mab and intracellular ATP synthesis. … (more)
- Is Part Of:
- FEBS journal. Volume 289:Number 20(2022)
- Journal:
- FEBS journal
- Issue:
- Volume 289:Number 20(2022)
- Issue Display:
- Volume 289, Issue 20 (2022)
- Year:
- 2022
- Volume:
- 289
- Issue:
- 20
- Issue Sort Value:
- 2022-0289-0020-0000
- Page Start:
- 6308
- Page End:
- 6323
- Publication Date:
- 2022-06-05
- Subjects:
- bioenergetics -- F‐ATP synthase -- mycobacteria -- NMR spectroscopy -- oxidative phosphorylation -- ε enzyme inhibitor
Biochemistry -- Periodicals
Molecular biology -- Periodicals
Pathology, Molecular -- Periodicals
572 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01038983-000000000-00000 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ejb ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ejb ↗ - DOI:
- 10.1111/febs.16536 ↗
- Languages:
- English
- ISSNs:
- 1742-464X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3901.578500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24288.xml